Prime Pharmaceuticals Private Limited, a active private limited company, was established on 11 September 1995 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24231MH1995PTC092543. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹6.18 M.
Formerly known as Prime Pharmaceuticals Limited. It upholds a compliant status. Employing 41 professional, Its leadership includes Devang Subodh Thakar (Director), Manish Patel (Director), Manish Navnitrai Vora (Director). Past directors included Anil Kumar Vora, Manish Navnitrai Vora, Ramamurthy Ayyavuthevar. It holds ₹85.00 Cr open charges and ₹17.35 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 601, 6Th Floor, Kamla Executive Park,, A K Road, Andheri East,, Mumbai, Maharashtra, 400059.
U24231MH1995PTC092543
092543
11 September 1995
₹2.00 Cr
₹6.18 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Prime Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devang Subodh Thakar | Director | 02 Apr 1998 | Current |
| Manish Patel | Director | 02 Apr 1998 | Current |
| Manish Navnitrai Vora | Director | 23 May 2024 | Current |
| Ramamurthy Ayyavuthevar | Director | 05 Feb 2021 | Current |
| Ashish Anil Vora | Director | 11 Sep 1995 | Current |
| Irfan Vazirally | Director | 20 May 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Jul 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 01 Sep 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Prime Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 147.64% increase. The company also saw a substantial improvement in profitability, with a 170.42% increase in profit. The company's net worth Soared by an impressive increase of 125%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Prime Pharmaceuticals had a promoter holding of 85.00% and a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹850,000,000.00
₹173,475,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Nov 2024 | Others | ₹20.00 Cr | Open |
| 18 May 2023 | Citi Bank N.A. | ₹65.00 Cr | Open |
| 17 Jul 2021 | Others | ₹5.00 M | Satisfied |
| 25 May 2021 | Others | ₹7.50 M | Satisfied |
| 06 May 2017 | Others | ₹10.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Prime Pharmaceuticals has a workforce of 41 employees as of Mar 11, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Prime Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prime Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Citi Bank N.A. of Rs. 65.00 Cr registered on 18 May 2023 with Charge ID 100722743 was modified on 22 Jan 2025. was documented.
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101014284 was registered on 28 Nov 2024. was recorded as a recent event.
Prime Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Manish Navnitrai Vora was appointed as a Director was appointed as a Director on 23 May 2024 & has been associated with this company since 1 year 6 months . was documented.
Prime Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity A charge registered on 17 Jul 2021 via Charge ID 100463484 with Others was fully satisfied on 20 Jun 2023. was completed.
The CIN of Prime Pharmaceuticals Private Limited is U24231MH1995PTC092543.
Prime Pharmaceuticals Private Limited is headquartered at 601, 6Th Floor, Kamla Executive Park,, A K Road, Andheri East,, Mumbai, Maharashtra, 400059.
Prime Pharmaceuticals Private Limited was incorporated on 11 September 1995.
The current directors of Prime Pharmaceuticals Private Limited are
The primary industry of Prime Pharmaceuticals Private Limited is Manufacturing.
Prime Pharmaceuticals Private Limited is unlisted.
The authorized capital of Prime Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹6.18 M.
The compliance status of Prime Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX